Sort
15,842 grants matching “pancreatic cancer”
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
$597,598Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
$597,598Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$597,485Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2011 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$597,448Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2007 · CA
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$597,411Maria Pisu · University Of Alabama At Birmingham · R01 · FY2023 · MD
Animal Core Facility
$597,320John Curlee Wilkinson · North Dakota State University · P20 · FY2024 · GM
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$597,298Farrokh Dehdashti · Washington University · R01 · FY2021 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy
$597,297Konstantin V Sokolov · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$597,261Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2012 · CA
North American Pancreatitis Study 2 (NAPS2)
$597,256University Of Pittsburgh At Pittsburgh · R01 · FY2004 · DK
Animal Core Facility
$597,234John Curlee Wilkinson · North Dakota State University · P20 · FY2023 · GM
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
$597,211David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
In Vivo Base Editing for Precision Oncology Models
$597,206Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Targeting B7-H3 in ovarian cancer
$597,170Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$597,140Shan Zha · Columbia University Health Sciences · R01 · FY2022 · CA
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
$597,107Aatur Dilip Singhi · University Of Pittsburgh At Pittsburgh · R37 · FY2022 · CA
Development and Implementation of ElectronicDecision Aids for Genetic Testing in Inherited Cancer Syndromes
$597,088Daniel C Chung · Massachusetts General Hospital · U01 · FY2022 · CA
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$596,833Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$596,660Jirong Long · Vanderbilt University · R01 · FY2011 · CA
Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia
$596,613Oleh Taratula · Oregon State University · R01 · FY2020 · CA
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
$596,548Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
Mechanistic Pharmacokinetics and Pharmacodynamics
$596,511William J Jusko · State University Of New York At Buffalo · R35 · FY2022 · GM
Modeling response to MAPK Inhibitors
$596,448Wolfgang Michael Korn · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2011 · CA
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$596,423Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Common and rare sequence variants in breast cancer risk
$596,399Sean Vahram Tavtigian · University Of Utah · R01 · FY2018 · CA